A detailed history of Zions Bancorporation, N.A. transactions in Incyte Corp stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 153 shares of INCY stock, worth $11,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153
Previous 197 22.34%
Holding current value
$11,097
Previous $11,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$57.33 - $68.61 $2,522 - $3,018
-44 Reduced 22.34%
153 $10,000
Q2 2024

Aug 08, 2024

BUY
$51.18 - $63.75 $3,121 - $3,888
61 Added 44.85%
197 $11,000
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $735 - $865
-13 Reduced 8.72%
136 $7,000
Q4 2023

Feb 12, 2024

SELL
$52.16 - $64.19 $7,511 - $9,243
-144 Reduced 49.15%
149 $9,000
Q3 2023

Nov 07, 2023

BUY
$57.77 - $65.93 $3,812 - $4,351
66 Added 29.07%
293 $16,000
Q2 2023

Jul 28, 2023

BUY
$60.95 - $75.51 $792 - $981
13 Added 6.07%
227 $14,000
Q4 2022

Feb 10, 2023

SELL
$67.18 - $84.11 $1,948 - $2,439
-29 Reduced 11.93%
214 $17,000
Q3 2022

Nov 08, 2022

SELL
$66.18 - $82.86 $1,919 - $2,402
-29 Reduced 10.66%
243 $16,000
Q2 2022

Aug 05, 2022

BUY
$66.18 - $83.18 $9,794 - $12,310
148 Added 119.35%
272 $21,000
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $4,819 - $5,818
73 Added 143.14%
124 $10,000
Q4 2021

Feb 11, 2022

SELL
$63.34 - $74.11 $1,963 - $2,297
-31 Reduced 37.8%
51 $4,000
Q3 2021

Nov 10, 2021

SELL
$68.67 - $84.02 $961 - $1,176
-14 Reduced 14.58%
82 $6,000
Q2 2021

Aug 11, 2021

BUY
$79.87 - $87.53 $718 - $787
9 Added 10.34%
96 $8,000
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $3,040 - $4,020
-40 Reduced 31.5%
87 $7,000
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $2,260 - $2,735
28 Added 28.28%
127 $11,000
Q3 2020

Nov 13, 2020

BUY
$85.07 - $109.69 $1,020 - $1,316
12 Added 13.79%
99 $9,000
Q2 2020

Aug 13, 2020

SELL
$74.18 - $108.93 $1,780 - $2,614
-24 Reduced 21.62%
87 $9,000
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $3,032 - $4,126
-48 Reduced 30.19%
111 $8,000
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $2,483 - $3,254
-34 Reduced 17.62%
159 $14,000
Q1 2019

May 10, 2019

SELL
$63.56 - $88.17 $127 - $176
-2 Reduced 1.03%
193 $17,000
Q4 2018

Feb 13, 2019

BUY
$58.5 - $69.94 $11,407 - $13,638
195 New
195 $12,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.